JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...

Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research Pulse, a new content-driven, thought leadership initiative ...

Pertussis Treatment Market Pertussis Medications and Vaccinations Leading Therapeutic Approaches Driving Stance of Companies in the Market: ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

In its third-quarter results update, the company confirmed that it is halting further development of fasinumab, an NGF drug partnered with Teva and Mitsubishi Tanabe Pharma that was in phase 3 ...

It could face competition from other subcutaneous infusion therapies, notably Mitsubishi Tanabe Pharma's ND-0612 which is in late-stage clinical testing. President Trump has withdrawn his ...

Heffel Fine Art Auction House hosted its highly-anticipated spring auction, showcasing more than 90 outstanding works of art to a packed sale room, buzzing with excitement. Works by Jean Paul Riopelle ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. The White House withdrew President Donald Trump's nomination of former ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...